For the year ending 2025-12-31, UTGN had -$14,726,995 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 17,166,898 |
| Amortization (accretion) of investments | -217,300 |
| Other-than-temporary impairments | 725,032 |
| Realized investment gains, net | 2,539,132 |
| Change in fair value of equity securities | 21,577,231 |
| Change in allowance from credit losses | -75,000 |
| Amortization of cost of insurance acquired | 614,166 |
| Provision for deferred income taxes | 2,848,451 |
| Depreciation and depletion | 1,280,023 |
| Stock-based compensation | 291,401 |
| Charges for mortality and administration of universal life and annuity products | 5,372,985 |
| Interest credited to account balances | 3,452,626 |
| Change in accrued investment income | -135,277 |
| Change in reinsurance receivables | -775,303 |
| Change in policy liabilities and accruals | -4,084,060 |
| Change in income taxes receivable | 775,428 |
| Change in other assets and liabilities, net | 1,153,511 |
| Net cash used in operating activities | -6,520,014 |
| Fixed maturities available for sale | 12,500,000 |
| Equity securities | 7,466,959 |
| Trading securities | 0 |
| Mortgage loans | 3,347,853 |
| Real estate | 88,151 |
| Notes receivable | 9,466,891 |
| Policy loans | 1,136,488 |
| Short-term investments | 2,000,000 |
| Total proceeds from investments sold and matured | 36,006,342 |
| Fixed maturities available for sale | 4,996,042 |
| Equity securities | 14,627,751 |
| Trading securities | 0 |
| Mortgage loans | 1,447,176 |
| Real estate | 5,793,421 |
| Notes receivable | 5,443,133 |
| Policy loans | 805,087 |
| Short-term investments | 9,781,441 |
| Total cost of investments acquired | 42,894,051 |
| Net cash provided by investing activities | -6,887,709 |
| Policyholder contract deposits | 3,842,569 |
| Policyholder contract withdrawals | 4,281,960 |
| Payments of principal on notes payable/line of credit | 0 |
| Purchase of treasury stock | 782,812 |
| Noncontrolling (distributions) of consolidated subsidiary | -97,069 |
| Net cash used in financing activities | -1,319,272 |
| Net increase (decrease) in cash and cash equivalents | -14,726,995 |
| Cash and cash equivalents at beginning of period | 45,263,967 |
| Cash and cash equivalents at end of period | 30,536,972 |
UTG INC (UTGN)
UTG INC (UTGN)